Podcasts and Videos - BioPharm International

ADVERTISEMENT

Podcasts and Videos

Sponsored Podcasts and Videos
Latest Editorial Podcasts and Videos
Webcasts
Archives

Sponsored podcasts and videos

More podcast coming soon.

Editorial Podcasts and Videos

The editorial team of BioPharm International present their podcast series, covering all the hottest industry trends from protein expression to biosimilars and regulatory expectations.

Viral Destruction- Sponsored Q&A by Microthermics
A range of industries-biotechnology, food and pharmaceuticals-must keep viral contamination out of their products. To do this effectively, a company needs a reliable, continuous process, and one that can be scaled to the company?s specific needs. To explore these topics, BioPharm International talked with John Miles, PhD, president and founder of MicroThermics Inc. This company specializes in small-scale solutions in high-temperature short-time (HTST) and ultra-high temperature (UHT) processes.


Archives

2012

Key Value Considerations for Growing BioPharm Product Pipeline. Part II
In part II of this BioPharm International interview, Tarja Mottram, CEO of Action for Results, focuses on design for value - a paradigm shift in how the industry measures and provides evidence for the impact of a product on healthcare outcomes. Posted Feb. 2012. Listen now

Key Considerations for Commercializing a Compound
Joerg Zimmerman, director of process development and implementation at Vetter discusses the need to think carefully about the commercialization efforts that must be applied to a compound under development. Posted Jan. 2012 as part of BioPharm International's Basic Training Drug Development series. Listen now


2011

Key Biosimilar Development in a Virtual Biotech Environment - Part II
Biosimilar development is not about conducting breakthrough research. Rather, it is about hitting the ground running and pressing the fast-forward button by using existing technologies to ensure first-in-class market access. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Biosimilar Development in a Virtual Biotech Set-up - Part I
In this article, the co-founder and CEO of Finox Biotech shares insight into their approach to biosimilar development. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Finox Biotech's Anjan Selz discusses the need for strong product differentiation
In this final podcast of three, Anjan Selz, cofounder and CEO of Finox Biotech, denounces the destructive nature of focusing only on price in the biosimilar space. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Finox Biotech's Anjan Selz on Meeting Regulatory Expectations
In this second of three podcasts, Anjan Selz, cofounder and CEO of Finox Biotech, discusses his company's interactions with EMA and FDA. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Finox Biotech's Anjan Selz on Biosimilar Development
In this first of three podcasts, Anjan Selz, cofounder and CEO of Finox Biotech, describes how he decided to move away from the 'me too' approach to biosimilars and focus on product differentiation. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

The Future of Drug Design
In this final podcast of three, BioPharm International interviews Dr. Trevor Hallam, chief scientific officer at Sutro Biopharma, a company that has developed a cell-free system for protein expression. Posted Dec. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Future GMP Manufacturing Facility
In this second of three podcast interviews, Dr. Hallam, chief scientific officer at Sutro Biopharma, describes a future GMP facility for the production therapeutic proteins and peptides. Posted December 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

MicroRNA Drug Delivery
Balkrishnen Bhat, senior director and head of chemistry at Regulus, discusses core technology in microRNA drug delivery. Posted Nov. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Cell-free Protein Expression
Dr. Trevor Hallam, chief scientific officer at Sutro Biopharma, discusses a nontraditional approach for expressing therapeutic proteins and peptides. Posted Nov. 2011 as part of BioPharm International's Basic Training Drug Development series. Listen now

Alnylam Discusses RNAi Delivery
Alnylam Pharmcaeuticals, a company specializing in RNA-interference therapeutics, talks to BioPharm International's Amy Ritter about its RNAi delivery system and its early-stage clinical pipeline. Posted August 2011. Listen now

Should Pharma Invest in R&D or Search for External Drug Candidates?
Join Shire's Renee Cohen, Sanofi's Ray Jupp, Deutsche Bank's Barbara Ryan, Ken Kaitin of Tufts University, and Charlotte Sibley as they debate how pharma can find new drug candidates and refill the pipeline. Posted July 2011. Watch now

USP 2011 Symposium Preview
A series of videos from the US Pharmacopeia (USP) provides highlights of the 2011 USP Science & Standards Symposium on Biologics & Biotechnology, which took place Oct. 3-6, 2011, in Seattle in the US. Posted September 2011. Watch now

Vermont's Data Mining Law
Physician privacy vs. Rep Free Speech: Before the Supreme Court decides Sorrell v. IMS Health, find out what's at stake. Jody Fisher, vice-president of marketing for SDI and Frank Pasquale, the Schering-Plough Professor in Health Care Regulation and Enforcement at Seton Hall Law School, face off in this episode of Pharma Faceoff. Posted July 2011. Watch now

A Conversation with NIH Director Francis S. Collins
Director of the National Institutes of Health (NIH), Dr. Francis Collins, discusses NIH's efforts to improve global healthcare, including an update on the human genome project, a focus on infectious and rare diseases in the developing world, and R&D grants for small businesses. Podcast interview by Sr. Managing Editor Angie Drakulich, as part of the 2011 BIO Convention and BioVentures for Global Health Partnering for Global Health Forum. Posted June 2011. Listen now


2010

Opportunities in Biosimilars
Michael Kamarck, president of Merck BioVentures, talks about the opportunities and challenges in biosimilars. Posted July 2010. Listen now

Using Stability Models to Predict Drug Characteristics at the End of Shelf Life
Listen to this interview with Peter Sprinz, PhD, a senior research scientist at Eli Lilly, to learn about using stability models to predict drug characteristics at the end of shelf life. Posted June 2010. Listen now

Microbial Fermenter Equipment Calibration
Kirsten Hayda, process development engineer at Amgen, discusses the benefits of testing fermentation equipment. Posted June 2010. Listen now

Biopharmaceutical Manufacturing in India: The Challenges
In this interview, Ajit Mahadevan, Leader of Biotech initiatives for the India Life Sciences Practices at Ernst & Young, discusses current trends and challenges of outsourcing biomanufacturing-related activities to India. Posted March 2010. Listen now

Solving Tomorrow's Downstream Processing Challenges
Listen in and hear tips for using improved processing technologies, better analytics, and advanced process development tools. acquisition? Posted March 2010. Listen now

Pfizer's Maddaluna on Integrating Wyeth's Manufacturing Organization
What is the future of Pfizer's global manufacturing network following the Wyeth acquisition? Posted Feb. 2010. Listen now

Quality by Design: Where We Stand Now
On what aspects of Quality by Design is there now consensus within the industry and regulatory bodies, and what remains to be sorted out? Posted Feb. 2010. Listen now

Biopharmaceutical Job Market: 2010 & Beyond
Current and future employment trends for the biopharmaceutical industry. Posted Jan. 2010. Listen now


2009

The Environmental Impact of Disposables
Are single-use technologies bad for the environment? Posted Jan. 2009. Listen now

 

ADVERTISEMENT

ADVERTISEMENT

Click here